Next Article in Journal
Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease
Next Article in Special Issue
Sirtuin 3 (SIRT3) Pathways in Age-Related Cardiovascular and Neurodegenerative Diseases
Previous Article in Journal
In Vivo Experimental Endovascular Uses of Cyanoacrylate in Non-Modified Arteries: A Systematic Review
Previous Article in Special Issue
Normalizing HIF-1α Signaling Improves Cellular Glucose Metabolism and Blocks the Pathological Pathways of Hyperglycemic Damage
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 9
Issue 9
10.3390/biomedicines9091283
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Nephroprotective Role of Chrysophanol in Hypoxia/Reoxygenation-Induced Renal Cell Damage via Apoptosis, ER Stress, and Ferroptosis

by
Chih-Hung Lin
1,2,3,†,
Han-Fang Tseng
4,†,
Po-Chun Hsieh
5,†,
Valeria Chiu
6,7,
Ting-Yun Lin
7,8,
Chou-Chin Lan
7,9,
I-Shiang Tzeng
10,
Huan-Nung Chao
11,
Chia-Chen Hsu
10 and
Chan-Yen Kuo
10,12,*
1
Department of Internal Medicine, Cathay General Hospital, Taipei 106, Taiwan
2
School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan
3
Ph.D. Program in Nutrition and Food Science, Fu Jen Catholic University, New Taipei City 242, Taiwan
4
Department of Anesthesiology, Taichung Veterans General Hospital, Taichung 407, Taiwan
5
Department of Chinese Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan
6
Division of Physical Medicine and Rehabilitation, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan
7
Department of Medicine, Tzu-Chi University, Hualien 970, Taiwan
8
Division of Nephrology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan
9
Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan
10
Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan
11
Department of Nephrology, Hanming Christian Hospital, Changhua City 500, Taiwan
12
Department of Nursing, Cardinal Tien College of Healthcare and Management, New Taipei City 231, Taiwan
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Biomedicines 2021, 9(9), 1283; https://doi.org/10.3390/biomedicines9091283
Submission received: 10 August 2021 / Revised: 11 September 2021 / Accepted: 18 September 2021 / Published: 21 September 2021
(This article belongs to the Special Issue Mitochondrial Dysfunction and Oxidative Stress in Aging and Disease)
Browse Figures
Versions Notes

Abstract

:
Acute kidney injury (AKI) is caused by hypoxia-reoxygenation (H/R), which is a kidney injury produced by a variety of causes, resulting in the remaining portion of the kidney function being unable to maintain the balance for performing the tasks of waste excretion metabolism, and electrolyte and acid-base balance. Many studies have reported the use of Chinese medicine to slow down the progression and alleviate the complications of chronic renal failure. Chrysophanol is a component of Rheum officinale Baill, a traditional Chinese medicine that has been clinically used to treat renal disease. We aimed to study the nephroprotective effect of chrysophanol on hypoxia/ reoxygenation (H/R)-induced cell damage. The results showed that chrysophanol prevented H/R-induced apoptosis via downregulation of cleaved Caspase-3, p-JNK, and Bax but upregulation of Bcl-2 expression. In contrast, chrysophanol attenuated H/R-induced endoplasmic reticulum (ER) stress via the downregulation of CHOP and p-IRE1α expression. Our data demonstrated that chrysophanol alleviated H/R-induced lipid ROS accumulation and ferroptosis. Therefore, we propose that chrysophanol may have a protective effect against AKI by regulating apoptosis, ER stress, and ferroptosis.

1. Introduction

It is well known that acute kidney injury (AKI) is a clinical syndrome characterized by a rapid loss of renal function that may further develop into chronic kidney disease (CKD) or even end-stage renal disease (ESRD) [1]. Many studies have reported the use of Chinese medicine to slow down the progression and alleviate the complications of acute renal failure, thereby improving quality of life [2,3]. In a cisplatin-induced AKI mouse model, wogonin reversed abrupt kidney dysfunction by substantially suppressing the increased levels of serum creatinine and blood urea nitrogen (BUN) to almost normal levels [4]. According to the literature on Chinese herbal intervention in AKI, Chinese herbs have been reported to play a critical role in the management of AKI by promoting repair and regeneration, enhancing extrarenal clearance of uremic toxins, and preventing progression to CKD [5,6]. Therefore, determining the best possible treatment may be a good strategy to attenuate or prevent renal injury in AKI.
Chrysophanol is a natural anthraquinone, also known as 1,8-dihydroxy-3-methyl-anthraquinone and chrysophanic acid, and is widely used in the food and pharmaceutical industries [7]. Moreover, chrysophanol has been reported to have various pharmacological properties, including antidiabetic, anticancer, neuroprotective, hepatoprotective, anti-ulcer, anti-inflammatory, antiviral, antifungal, and antibacterial activities [8]; however, the effect of chrysophanol on AKI remains unclear. AKI is a major cause of renal ischemia–reperfusion (I/R) or hypoxia-reperfusion or hypoxia-reoxygenation (H/R), as demonstrated in cell lines and mouse models [9,10]. Accumulating evidence indicates that proximal tubular cells (HK-2 cells) are sensitive to renal I/R [11,12,13].
Endoplasmic reticulum (ER) stress is the major cause of renal cell damage during the progression of AKI by renal I/R [14]. Furthermore, excessive reactive oxygen species (ROS) that cause oxidative stress may contribute to the increased susceptibility of the aging kidney in prolonging ER stress-induced acute injury [15]. Mounting evidence indicates that ER stress contributes to glomerular and tubular damage in patients with acute and chronic kidney disease [16]. Therefore, modulation and normalization of ER stress in kidney cells using pharmacological agents may be a promising therapeutic approach for preventing the progression of kidney disease [17]. On the other hand, an increasing number of studies have significantly implicated ferroptosis, a unique type of regulated cell death that is characterized by a large amount of iron accumulation and lipid peroxidation during the cell-death process, in the development of acute kidney disease [18,19,20]. Altogether, targeting the homeostasis of ferroptosis may provide a new target for therapeutic intervention in AKI [21]. Shu et al. reported that I/R led to kidney injury via the underlying mechanism of ER stress as indicated by the increased expression of the C/EBP homologous protein (CHOP). Additionally, inhibition of ER stress prevents renal tubular epithelial cell apoptosis, inflammation, and autophagy caused by I/R [22].
Recent studies have revealed an emerging role of ferroptosis in the pathophysiological processes of AKI, which can eventually lead to acute renal failure (ARF) [19,23,24]. Yang and Stockwell suggested that the downregulation of GPX4 may be more sensitive to ferroptosis, whereas inhibition of ferroptosis was detected upon the upregulation of GPX4 in vitro [25]. Furthermore, SLC7A11 is a key regulator of ferroptosis [18]. It has also been reported that inhibiting SLC7A11 activity induces ROS accumulation and triggers ferroptosis [26].
In the present study, we investigated whether chrysophanol attenuated cell death in HK-2 cells exposed to H/R injury and exerted renal protection via modulation of apoptosis, ER stress, and ferroptosis.

2. Materials and Methods

2.1. Reagents and Antibodies

Chrysophanol (CAS 481-74-3) was purchased from Sigma (St. Louis, MO, USA). The chrysophanol was solved in DMSO (C6164, Sigma, St. Louis, MO, USA) for 30 mM. The cell proliferation reagents WST-1 and RNase A were obtained from Roche Applied Sciences (Mannheim, Germany). Deferoxamine mesylate salt (DFO, D9533, Sigma, St. Louis, MO, USA). The DFO was solved in phosphate-buffered saline (PBS, P5493, Sigma, St. Louis, MO, USA) for 0.1 M. The same volume of vehicle (DMSO or PBS) was added to the controls in this study.
The antibodies used for immunofluorescence staining and Western blotting were as follows: rabbit polyclonal antibodies against cleaved Caspase-3 (Cell Signaling Technology, Danvers, MA, USA), β-actin (Cell Signaling, Danvers, MA, USA), CHOP (ABclonal, Woburn, MA, USA), p-IRE1α (ABclonal, Woburn, MA, USA), IRE1α (ABclonal, Woburn, MA, USA), p-JNK (ABclonal, Woburn, MA, USA), JNK (ABclonal, Woburn, MA, USA), IL-6 (ABclonal, Woburn, MA, USA), GAPDH (Cell Signaling, Danvers, MA, USA), p65 (Cell Signaling Technology, Danvers, MA, USA), and fibrillin (Cell Signaling, Danvers, MA, USA).

2.2. Cell Culture and Hypoxia/Reoxygenation (H/R) Conditions

HK-2 cells (human renal proximal tubular epithelial cells) were purchased from BCRC (Bioresource Collection and Research Center, Hsinchu, Taiwan) and cultured in T-75 flasks (Corning, Corning, NY, USA) in DMEM/Ham’s F12 (Gibco, New York, NY, USA) supplemented with 10% heat-inactivated fetal bovine serum, 25 mM D-glucose, 2 mM L-glutamine, 1 mM sodium pyruvate, and penicillin-streptomycin (50 U/mL; Sigma, St. Louis, MO, USA) at 37 °C in 5% CO2/95% air. The culture medium was replaced with fresh medium on alternate days. Once the cells reached 60–70% confluence, they were trypsinized for subsequent experiments. Mycoplasma test results were negative.
Hypoxia/reoxygenation conditions were created using a previously described method with some modifications [27,28]. Briefly, cells were grown on 6- or 24-well plastic dishes in a hypoxia chamber and equilibrated for 30 min with humidified gas containing 1% oxygen, 5% CO2, and 94% nitrogen (Hypoxic incubator APM-30D, Astec, Tokyo, Japan). The cell lines were maintained under hypoxic conditions for 15 h and then additionally incubated under normoxic conditions for another 2 h. The normal group consisted of cells grown under normal (21%) oxygen conditions for the same duration.

2.3. Cell Viability Assay

Cell viability was measured using the WST-1 assay. Cells were seeded at a density of 5 × 104 cells/mL in 24-well plates and cultured in phenol red-free DMEM containing 0.5% heat-inactivated FBS for 24 h. Then, the cells were incubated with the indicated concentrations of chrysophanol (30 μM) for 24 h. The WST-1 reagent was then added to the medium and the cells were incubated at 37 °C for 2 h. The absorbance was measured at 450 nm using a microplate reader (Bio-Rad, Hercules, CA, USA).

2.4. Western Blotting

The cells 1 × 106 were harvested and lysed according to a protocol described in our previous study [29]. Briefly, cells were collected, washed three times with PBS and lysed using RIPA lysis buffer (Pierce, Rockford, IL, USA), containing 1% Sigma protease cocktail, for 30 min at 4 °C. The lysates were centrifuged at 10,000× g at 4 °C to obtain solubilized cellular proteins. The supernatant protein concentration was measured using a bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA). Proteins were separated by 8%, 10% or 12% SDS-PAGE and electro-transferred onto a polyvinylidene fluoride membrane. Blots were probed with specific primary antibodies and followed by HRP-conjugated goat anti-rabbit IgG (1:3000–1:5000) or HRP-conjugated goat anti-mouse IgG (1:5000) (Zymed, San Francisco, CA, USA). After washing with PBS containing 0.5% Tween-20, peroxidase activity was assessed using enhanced chemiluminescence (ECL; PerkinElmer Life Science, Hopkinton, MA, USA). The same membrane was re-probed with a monoclonal antibody directed against GAPDH or β-actin as a loading control (1:5000; GeneTex, Irvine, CA, USA). The intensities of the reaction bands were analyzed with the UVP Biospectrum (UVP, LLC Upland, CA, USA). The primary antibodies used are mentioned in Section 2.1 (Reagents and antibodies).

2.5. Lipid ROS Detection

Cells were incubated with 2 µM C11-BODIPY 581/591 (Thermo Fisher Scientific, Waltham, MA, USA) in culture medium for 1 h and then washed with phosphate-buffered saline (PBS). After trypsinization, cells were collected and processed for flow cytometry (BD Biosciences, San Jose, CA, USA) at an excitation wavelength of 488 nm and an emission wavelength of 517–527 nm.

2.6. Nuclear Fraction Extraction

The nuclear fraction was extracted from 1 × 106 HK-2 cells according to the protocol of a previous study [30]. Briefly, nuclear fraction was extracted from cells. The cells were collected and resuspended in a hypotonic buffer (10 mM HEPES, pH 7.9; 10 mM KCl; 1.5 mM MgCl2; 0.2 mM PMSF; 20 μg/mL aprotinin; 0.5 mM DTT; and 0.5% NP-40) on ice for 15 min. After centrifuging at 6000× g for 15 min at 4 °C, the pellet was collected and then washed with basal buffer (hypotonic buffer without 0.5% NP-40). After centrifuging again at 6000× g for 15 min at 4 °C, the pellet was collected and resuspended in a hypertonic buffer (20 mM HEPES, pH 7.9; 400 mM KCl; 1.5 mM MgCl2; 0.2 mM PMSF; 20 μg/mL aprotinin; 0.5 mM DTT; 0.2 mM EDTA; 10% glycerol) at room temperature for 30 min. After centrifuging at 10,000× g for 30 min at 4 °C, the nuclear fraction contained in the supernatant was collected.

2.7. Immunofluorescence Staining

The cells were fixed in 3% formaldehyde at room temperature for 30 min, blocked with PBS containing 3% FBS at room temperature for 1 h, and incubated with anti-p65 antibody and β-catenin at 4 °C for 16 h, followed by incubation with FITC-labeled secondary antibody (Jackson ImmunoResearch Laboratories, West Grove, PA, USA) at room temperature for 1 h. The nuclei were stained with diamidino-2-phenylindole (DAPI, Molecular Probes) at room temperature for 15 min, which is a DNA groove-binding dye, and examined using a Leica TCS SP5 laser scanning microscope (Leica, Bensheim, Germany).

2.8. Statistical Analyses

All data were analyzed using one-way or two-way analysis of variance (ANOVA). Differences were considered statistically significant when the p-values were less than 0.05 (* p < 0.05, ** p < 0.01).

3. Results

3.1. Chrysophanol Attenuated H/R-Induced Cell Death via Apoptosis

H/R significantly induced cell death in HK-2 cells, according to the cell viability analysis (Figure 1A). To determine the effect of chrysophanol on cell survival, cell viability was determined in cells treated with 30 μM chrysophanol prior to incubation under H/R conditions. Results showed that chrysophanol significantly alleviated H/R-induced cell viability (Figure 1A). To further study whether chrysophanol attenuated H/R-induced cell death via apoptosis, we detected the expression of cleaved Caspase-3, Bax, and Bcl-2 in the presence of 30 μM chrysophanol under H/R conditions. The results showed a decrease in cleaved Caspase-3 and Bax but an increase in Bcl-2 was observed in the presence of 30 μM chrysophanol under H/R conditions (Figure 1B, lane 2 vs. lane 4). These results indicated that chrysophanol attenuated H/R-induced cell death via apoptosis.

3.2. Chrysophanol Regulated ER Stress and Ferroptosis Pathway under H/R Conditions

To investigate the effect of chrysophanol on H/R-induced ER stress, we used Western blotting to examine the expression of CHOP and phosphorylated phosho-IRE1α (p-IRE1α) in the presence and absence of chrysophanol under H/R conditions. The results indicated that H/R increased the expression of CHOP and p-IRE1α (Figure 2A, lane 1 vs. lane 2). On the other hand, chrysophanol reversed the upregulation of CHOP and p-IRE1α under H/R conditions (Figure 2A, lane 2 vs. lane 4).
In this study, results showed that H/R increased the expression of GPX4 and SLC7A11 (Figure 2B, lane 1 vs. lane 2). On the other hand, chrysophanol reversed the upregulation of GPX4 and SLC7A11 under H/R conditions (Figure 2B, lane 2 vs. lane 4). To further confirm the anti-ferroptotic effect of chrysophanol under H/R conditions, we measured the levels of lipid ROS (Figure 3). To further verify the role of iron under H/R conditions, we detected the levels of lipid ROS and cell viability in presence of DFO (iron chelator). Results showed that the DFO attenuated the increase (Figure 3C,D) and the decrease in cell viability under H/R conditions (Figure 3E). Taken together, we suggest that chrysophanol regulates ER stress and the ferroptosis pathway under H/R conditions.

3.3. Chrysophanol Treatment Attenuated p-JNK Expression and NF-κB Nuclear Translocation under H/R Conditions

Our results demonstrated that H/R increased the expression of p-JNK (Figure 2A, lane 1 vs. lane 2) and NF-κB nuclear translocation (Figure 4A, lane 5 vs. lane 6). On the other hand, we also found that chrysophanol reversed the increase in p-JNK expression (Figure 2A, lane 2 vs. lane 4) and the expression of NF-κB nuclear translocation under H/R conditions (Figure 4A, lane 6 vs. lane 8). The quantitative results were shown in Figure 4B. Additionally, to further confirm the effect of chrysophanol on β-catenin and NF-κB p65 nuclear translocation under H/R conditions, we performed immunofluorescence staining (Figure 4C,D and Supplementary Materials Figure S1). Moreover, results also demonstrated that chrysophanol alleviated the increase in IL-6 expression under H/R conditions (Figure 4E). These results indicated that chrysophanol treatment attenuated p-JNK expression and NF-κB nuclear translocation under H/R conditions.

4. Discussion

In this study, we proposed that chrysophanol has a nephroprotective effect on renal cell damage caused by H/R. Additionally, we also suggested that apoptosis, ER stress, and ferroptosis, which are involved in H/R-induced cell death, were reversed in the presence of chrysophanol. Havasi and Borkan demonstrated that the improvement of renal cell death in AKI generated new therapeutic targets [31]. Interestingly, proximal tubular epithelial cells were reported to be highly susceptible to apoptosis, and injury at this site contributes to kidney failure [31]. Human renal proximal tubular cells (HK-2) were established as a cell model of hypoxia-reoxygenation (H/R) injury to mimic acute renal I/R injury [32], as well as our findings (Figure 1). Traditional medicines often use multi-component extracts of natural products that may be developed as therapeutic strategies to treat AKI due to their multitarget potential and established biosafety [33]. Rhus verniciflua Stokes extract was reported to prevent the progression of AKI via modulation of the Nrf2/antioxidant enzyme pathway, using in vivo and in vitro I/R injury (IRI)-induced AKI models [34]. Similarly, Taraxacum officinale has a protective effect on H/R-induced AKI via inhibition of oxidative stress, inflammation, and apoptosis in the extracellular signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK) of the mitogen-activated protein kinase (MAPK) signaling pathways in vivo and in vitro [35]. Accumulating evidence has revealed that natural products or herbs may have potential for use in the clinical treatment of renal H/R injury [36,37,38], but resveratrol did not protect against H/R-induced AKI in vivo [39].
It is well known that regulating ER stress in kidney cells may provide a therapeutic target in AKI that is caused by H/R [14,16,40,41]. As shown in Figure 2A, H/R-induced ER stress was attenuated by chrysophanol treatment. Consistent with our findings, Huaier extract was found to downregulate the expression of CHOP and Bip in a thapsigargin-induced ER stress model of HK-2 cells [42]; the same result was also observed in other studies [27]. On the other hand, ferroptosis is well known to play a critical role in the pathology of AKI [19]. Quercetin (QCT) was reported to inhibit ferroptosis, but not apoptosis, necrosis, or autophagy, in renal proximal tubular epithelial cells and ameliorate AKI induced by I/R or folic acid (FA) [43]. In this study, chrysophanol attenuated H/R-induced ferroptosis via the regulation of GPX4 and SLC7A11, as seen on Western blot (Figure 2B) and BODIPY C11 fluorescence staining (Figure 3) in HK-2 cells, similar to the results obtained in other studies [44,45]. Therefore, chrysophanol ameliorated renal cell injury with H/R, perhaps by inhibiting ferroptosis. Chrysophanol may represent a novel treatment option that improves recovery from H/R-induced renal tubular cell injury by targeting ferroptosis. It is also possible that chrysophanol acts as an antioxidant, which may consequently increase the antioxidative capacity of the cells and elevate the expression of GXP4 and SLC7A11.
NF-κB signaling was reported to play a major role in the regulation of kidney injury [46]. Tubular injury was rescued by inhibiting NF-κB signaling in the renal tubular epithelium in vivo [47]. In addition, apoptotic tubular cell death was determined via downregulation of the Wnt/β-catenin dependent pathway by Dickkopf-3 in proteinuric nephropathy [48]. However, the conflicting role of the Wnt/β-catenin signaling pathway in kidney diseases and kidney injury repair or regeneration is determined by whether kidney structure and function are “reversible” or “irreversible” after injury. Therefore, further elucidation of the mechanisms by which Wnt/β-catenin acts in AKI and CKD may offer new therapeutic options for patients with various kidney diseases [49].
Cisplatin is one of the most widely used chemotherapeutic agents for treating solid tumors, but the administration of cisplatin causes tubular cell injury and AKI [50,51]. Maltol (3-hydroxy-2-methyl-4-pyrone), found in baked products as well as red ginseng root, coffee, chicory, soybeans, bread crusts, and caramelized foods [52], was reported to serve as a valuable potential drug to prevent cisplatin-induced nephrotoxicity [53]. Ridzuan et al. summarized several studies reporting that natural products possess potent antioxidant and anti-inflammatory medicinal properties, and they can be safely used as a supplementary regime or during combination therapy against cisplatin-induced nephrotoxicity [54]. In a future study, we will investigate whether chrysophanol alleviates cisplatin-induced nephrotoxicity.

5. Conclusions

In summary, the present study demonstrated that chrysophanol prevented H/R-induced cell death via apoptosis by increasing the expression of Bax, and p-JNK but decreasing the expression of Bcl-2, as well as prolonging ER stress by increasing the expression of CHOP and p-IRE1α, finally increasing the expression of cleaved Caspase-3 (Figure 5A). Additionally, chrysophanol attenuated the apoptosis via inhibition of apoptotic molecules, triggering the expression of anti-apoptotic molecules and inhibition of ER stress (Figure 5A). We also suggested that H/R induced HK-2 cell death by triggering ferroptosis via lipid ROS accumulation and downregulation of anti-ferroptotic molecules, GPX4 and SLC7A11 (Figure 5B). On the other hand, chrysophanol showed potential anti-ferroptotic effects in HK-2 cells under H/R conditions via upregulation of GPX4 and SCL7A11 and alleviating lipid ROS accumulation (Figure 5B)

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/biomedicines9091283/s1, Figure S1: Effect of chrysophanol on nuclear translocation of β-catenin and p65 under normoxia.

Author Contributions

C.-H.L., H.-F.T., P.-C.H., V.C., T.-Y.L., C.-C.L., I.-S.T., H.-N.C., C.-C.H. and C.-Y.K. made substantial contributions to the conception and design. C.-H.L., H.-F.T., P.-C.H. and C.-Y.K. wrote the manuscript. V.C., T.-Y.L., C.-C.L., I.-S.T., H.-N.C. and C.-C.H. interpreted and analyzed the data, along with C.-Y.K. All authors have read and agreed to the published version of the manuscript.

Funding

The grants supported by this study include CGH-MR-A11004 from Cathay General Hospital, Taipei, Taiwan. This work was also supported by a grant from the Ministry of Science and Technology, Taiwan (109-2320-B-303-004-MY3).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original data used to support the findings of this study are included in this article.

Acknowledgments

We appreciate the work of the research assistants Ming-Cheng Lee in troubleshooting the Western blot assays.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kalantar-Zadeh, K.; Jafar, T.H.; Nitsch, D.; Neuen, B.L.; Perkovic, V. Chronic kidney disease. Lancet 2021, 398, 786–802. [Google Scholar] [CrossRef]
  2. Li, H.D.; Meng, X.M.; Huang, C.; Zhang, L.; Lv, X.W.; Li, J. Application of herbal traditional Chinese medicine in the treatment of acute kidney injury. Front. Pharmacol. 2019, 10, 376. [Google Scholar] [CrossRef]
  3. Yang, B.; Xie, Y.; Guo, M.; Rosner, M.H.; Yang, H.; Ronco, C. Nephrotoxicity and Chinese herbal medicine. Clin. J. Am. Soc. Nephrol. 2018, 13, 1605–1611. [Google Scholar] [CrossRef]
  4. Meng, X.M.; Li, H.D.; Wu, W.F.; Ming-Kuen Tang, P.; Ren, G.L.; Gao, L.; Li, X.F.; Yang, Y.; Xu, T.; Ma, T.T.; et al. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis. Lab. Investig. 2018, 98, 79–94. [Google Scholar] [CrossRef] [Green Version]
  5. Isnard Bagnis, C.; Deray, G.; Baumelou, A.; Le Quintrec, M.; Vanherweghem, J.L. Herbs and the kidney. Am. J. Kidney Dis. 2004, 44, 1–11. [Google Scholar] [CrossRef]
  6. Valerian Bunel, F.Q.; Duez, P.; Xu, Q.-H. Herbal medicines for acute kidney injury: Evidence, gapsand frontiers. World J. Tradit. Chin. Med. 2015, 1, 47–66. [Google Scholar] [CrossRef]
  7. Xie, L.; Tang, H.; Song, J.; Long, J.; Zhang, L.; Li, X. Chrysophanol: A review of its pharmacology, toxicity and pharmacokinetics. J. Pharm. Pharmacol. 2019, 71, 1475–1487. [Google Scholar] [CrossRef] [Green Version]
  8. Prateeksha; Yusuf, M.A.; Singh, B.N.; Sudheer, S.; Kharwar, R.N.; Siddiqui, S.; Abdel-Azeem, A.M.; Fernandes Fraceto, L.; Dashora, K.; Gupta, V.K. Chrysophanol: A Natural Anthraquinone with Multifaceted Biotherapeutic Potential. Biomolecules 2019, 9, 68. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Fan, H.; Yang, H.C.; You, L.; Wang, Y.Y.; He, W.J.; Hao, C.M. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/reperfusion-induced acute kidney injury. Kidney Int. 2013, 83, 404–413. [Google Scholar] [CrossRef] [Green Version]
  10. Tanaka, S.; Tanaka, T.; Nangaku, M. Hypoxia as a key player in the AKI-to-CKD transition. Am. J. Physiol. Renal Physiol. 2014, 307, F1187–F1195. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Xiao, Y.; Yang, Y.; Cao, H.; Huang, Y.; Wang, H.; Zhao, B. Resveratrol protects human renal proximal tubular cells from high glucose and hypoxia/ reoxygenation induced injury via inhibiting p38-MAPK and thioredoxin-interacting protein (TXNIP) pathways. Int. J. Clin. Exp. Med. 2019, 12, 2243–2254. [Google Scholar]
  12. Luo, L.; Lu, J.; Wei, L.; Long, D.; Guo, J.Y.; Shan, J.; Li, F.S.; Lu, P.Y.; Li, P.Y.; Feng, L. The role of HIF-1 in up-regulating MICA expression on human renal proximal tubular epithelial cells during hypoxia/reoxygenation. BMC Cell Biol. 2010, 11, 91. [Google Scholar] [CrossRef] [Green Version]
  13. Xie, J.; Guo, Q. Apoptosis antagonizing transcription factor protects renal tubule cells against oxidative damage and apoptosis induced by ischemia-reperfusion. J. Am. Soc. Nephrol. 2006, 17, 3336–3346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Yan, M.; Shu, S.; Guo, C.; Tang, C.; Dong, Z. Endoplasmic reticulum stress in ischemic and nephrotoxic acute kidney injury. Ann. Med. 2018, 50, 381–390. [Google Scholar] [CrossRef]
  15. Liu, X.; Zhang, R.; Huang, L.; Zheng, Z.; Vlassara, H.; Striker, G.; Zhang, X.; Guan, Y.; Zheng, F. Excessive oxidative stress contributes to increased acute ER stress kidney injury in aged mice. Oxid. Med. Cell Longev. 2019, 2019, 2746521. [Google Scholar] [CrossRef]
  16. Inagi, R. Endoplasmic reticulum stress in the kidney as a novel mediator of kidney injury. Nephron Exp. Nephrol. 2009, 112, e1–e9. [Google Scholar] [CrossRef]
  17. Cybulsky, A.V. Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int. 2010, 77, 187–193. [Google Scholar] [CrossRef] [Green Version]
  18. Li, J.; Cao, F.; Yin, H.L.; Huang, Z.J.; Lin, Z.T.; Mao, N.; Sun, B.; Wang, G. Ferroptosis: Past, present and future. Cell Death Dis. 2020, 11, 88. [Google Scholar] [CrossRef] [PubMed]
  19. Hu, Z.; Zhang, H.; Yang, S.K.; Wu, X.; He, D.; Cao, K.; Zhang, W. Emerging role of ferroptosis in acute kidney injury. Oxid. Med. Cell Longev. 2019, 2019, 8010614. [Google Scholar] [CrossRef]
  20. Ma, D.; Li, C.; Jiang, P.; Jiang, Y.; Wang, J.; Zhang, D. Inhibition of ferroptosis attenuates acute kidney injury in rats with severe acute pancreatitis. Dig. Dis. Sci. 2020, 66, 483–492. [Google Scholar] [CrossRef]
  21. Borawski, B.; Malyszko, J. Iron, ferroptosis, and new insights for prevention in acute kidney injury. Adv. Med. Sci. 2020, 65, 361–370. [Google Scholar] [CrossRef]
  22. Shu, S.; Zhu, J.; Liu, Z.; Tang, C.; Cai, J.; Dong, Z. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease. EBioMedicine 2018, 37, 269–280. [Google Scholar] [CrossRef] [Green Version]
  23. Friedmann Angeli, J.P.; Schneider, M.; Proneth, B.; Tyurina, Y.Y.; Tyurin, V.A.; Hammond, V.J.; Herbach, N.; Aichler, M.; Walch, A.; Eggenhofer, E.; et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 2014, 16, 1180–1191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Malek, M.; Nematbakhsh, M. Renal ischemia/reperfusion injury; from pathophysiology to treatment. J. Renal Inj. Prev. 2015, 4, 20–27. [Google Scholar] [CrossRef]
  25. Yang, W.S.; Stockwell, B.R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 2008, 15, 234–245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Alvarez, S.W.; Sviderskiy, V.O.; Terzi, E.M.; Papagiannakopoulos, T.; Moreira, A.L.; Adams, S.; Sabatini, D.M.; Birsoy, K.; Possemato, R. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature 2017, 551, 639–643. [Google Scholar] [CrossRef] [PubMed]
  27. Yu, W.; Sheng, M.; Xu, R.; Yu, J.; Cui, K.; Tong, J.; Shi, L.; Ren, H.; Du, H. Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. J. Transl. Med. 2013, 11, 24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Xie, Y.; Jiang, D.; Xiao, J.; Fu, C.; Zhang, Z.; Ye, Z.; Zhang, X. Ischemic preconditioning attenuates ischemia/reperfusion-induced kidney injury by activating autophagy via the SGK1 signaling pathway. Cell Death Dis. 2018, 9, 338. [Google Scholar] [CrossRef]
  29. Kuo, C.Y.; Chiu, V.; Hsieh, P.C.; Huang, C.Y.; Huang, S.J.; Tzeng, I.S.; Tsai, F.M.; Chen, M.L.; Liu, C.T.; Chen, Y.R. Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis. J. Pharmacol. Sci. 2020, 144, 172–182. [Google Scholar] [CrossRef]
  30. Kuo, C.Y.; Lin, C.H.; Hsu, T. VHL inactivation in precancerous kidney cells induces an inflammatory response via ER stress-activated IRE1alpha signaling. Cancer Res. 2017, 77, 3406–3416. [Google Scholar] [CrossRef] [Green Version]
  31. Havasi, A.; Borkan, S.C. Apoptosis and acute kidney injury. Kidney Int. 2011, 80, 29–40. [Google Scholar] [CrossRef] [Green Version]
  32. Chen, C.; Cai, C.; Lin, H.; Zhang, W.; Peng, Y.; Wu, K. Baicalein protects renal tubular epithelial cells againsthypoxia-reoxygenation injury. Ren. Fail. 2018, 40, 603–610. [Google Scholar] [CrossRef] [PubMed]
  33. Zhong, Y.; Deng, Y.; Chen, Y.; Chuang, P.Y.; Cijiang He, J. Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney Int. 2013, 84, 1108–1118. [Google Scholar] [CrossRef] [Green Version]
  34. Choi, D.R.; Jeong, J.H.; Yu, K.S.; Lee, N.S.; Jeong, Y.G.; Kim, D.K.; Na, C.S.; Na, D.S.; Hwang, W.M.; Han, S.Y. Extract of Rhus verniciflua stokes protects against renal ischemia-reperfusion injury by enhancing Nrf2-mediated induction of antioxidant enzymes. Exp. Ther. Med. 2018, 15, 3827–3835. [Google Scholar] [CrossRef] [Green Version]
  35. Li, C.; Zheng, Z.; Xie, Y.; Zhu, N.; Bao, J.; Yu, Q.; Zhou, Z.; Liu, J. Protective effect of taraxasterol on ischemia/reperfusion-induced acute kidney injury via inhibition of oxidative stress, inflammation, and apoptosis. Int. Immunopharmacol. 2020, 89, 107169. [Google Scholar] [CrossRef]
  36. Liu, S.; Yang, Y.; Gao, H.; Zhou, N.; Wang, P.; Zhang, Y.; Zhang, A.; Jia, Z.; Huang, S. Trehalose attenuates renal ischemia-reperfusion injury by enhancing autophagy and inhibiting oxidative stress and inflammation. Am. J. Physiol. Renal Physiol. 2020, 318, F994–F1005. [Google Scholar] [CrossRef]
  37. Tian, R.; Wang, P.; Huang, L.; Li, C.; Lu, Z.; Lu, Z.; Wu, A.; Bao, K.; Mao, W.; Huang, Q.; et al. Sanqi oral solution ameliorates renal ischemia/reperfusion injury via reducing apoptosis and enhancing autophagy: Involvement of ERK/mTOR pathways. Front. Pharmacol. 2020, 11, 537147. [Google Scholar] [CrossRef] [PubMed]
  38. Wang, L.; Li, C.; Guan, C.; Zhang, Y.; Yang, C.; Zhao, L.; Luan, H.; Zhou, B.; Che, L.; Wang, Y.; et al. Nicotiflorin attenuates cell apoptosis in renal ischemia-reperfusion injury through ATF3. Nephrology 2020, 26, 358–368. [Google Scholar] [CrossRef] [PubMed]
  39. Bienholz, A.; Mae Pang, R.; Guberina, H.; Rauen, U.; Witzke, O.; Wilde, B.; Petrat, F.; Feldkamp, T.; Kribben, A. Resveratrol does not protect from ischemia-induced acute kidney injury in an in vivo rat model. Kidney Blood Press. Res. 2017, 42, 1090–1103. [Google Scholar] [CrossRef] [PubMed]
  40. Mahfoudh-Boussaid, A.; Zaouali, M.A.; Hadj-Ayed, K.; Miled, A.H.; Saidane-Mosbahi, D.; Rosello-Catafau, J.; Ben Abdennebi, H. Ischemic preconditioning reduces endoplasmic reticulum stress and upregulates hypoxia inducible factor-1alpha in ischemic kidney: The role of nitric oxide. J. Biomed. Sci. 2012, 19, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Mahfoudh-Boussaid, A.; Zaouali, M.A.; Hauet, T.; Hadj-Ayed, K.; Miled, A.H.; Ghoul-Mazgar, S.; Saidane-Mosbahi, D.; Rosello-Catafau, J.; Ben Abdennebi, H. Attenuation of endoplasmic reticulum stress and mitochondrial injury in kidney with ischemic postconditioning application and trimetazidine treatment. J. Biomed. Sci. 2012, 19, 71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Zhao, J.Y.; Wu, Y.B. Huaier extract attenuates acute kidney injury to chronic kidney disease transition by inhibiting endoplasmic reticulum stress and apoptosis via miR-1271 upregulation. Biomed. Res. Int. 2020, 2020, 9029868. [Google Scholar] [CrossRef]
  43. Wang, Y.; Quan, F.; Cao, Q.; Lin, Y.; Yue, C.; Bi, R.; Cui, X.; Yang, H.; Yang, Y.; Birnbaumer, L.; et al. Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J. Adv. Res. 2021, 28, 231–243. [Google Scholar] [CrossRef]
  44. Li, D.; Liu, B.; Fan, Y.; Liu, M.; Han, B.; Meng, Y.; Xu, X.; Song, Z.; Liu, X.; Hao, Q.; et al. Nuciferine protects against folic acid-induced acute kidney injury by inhibiting ferroptosis. Br. J. Pharmacol. 2021, 178, 1182–1199. [Google Scholar] [CrossRef] [PubMed]
  45. Yang, Y.; Cai, F.; Zhou, N.; Liu, S.; Wang, P.; Zhang, S.; Zhang, Y.; Zhang, A.; Jia, Z.; Huang, S. Dimethyl fumarate prevents ferroptosis to attenuate acute kidney injury by acting on NRF2. Clin. Transl. Med. 2021, 11, e382. [Google Scholar] [CrossRef] [PubMed]
  46. Song, N.; Thaiss, F.; Guo, L. NFkappaB and kidney injury. Front. Immunol. 2019, 10, 815. [Google Scholar] [CrossRef]
  47. Marko, L.; Vigolo, E.; Hinze, C.; Park, J.K.; Roel, G.; Balogh, A.; Choi, M.; Wubken, A.; Cording, J.; Blasig, I.E.; et al. Tubular epithelial NF-kappaB activity regulates ischemic AKI. J. Am. Soc. Nephrol. 2016, 27, 2658–2669. [Google Scholar] [CrossRef] [Green Version]
  48. Wong, D.W.; Yiu, W.H.; Wu, H.J.; Li, R.X.; Liu, Y.; Chan, K.W.; Leung, J.C.; Chan, L.Y.; Lai, K.N.; Tang, S.C. Downregulation of renal tubular Wnt/beta-catenin signaling by Dickkopf-3 induces tubular cell death in proteinuric nephropathy. Cell Death Dis. 2016, 7, e2155. [Google Scholar] [CrossRef]
  49. Zhou, D.; Tan, R.J.; Fu, H.; Liu, Y. Wnt/beta-catenin signaling in kidney injury and repair: A double-edged sword. Lab. Investig. 2016, 96, 156–167. [Google Scholar] [CrossRef] [Green Version]
  50. Garcia-Pastor, C.; Blazquez-Serra, R.; Bosch, R.J.; Lucio Cazana, F.J.; Fernandez-Martinez, A.B. Apoptosis and cell proliferation in proximal tubular cells exposed to apoptotic bodies. Novel pathophysiological implications in cisplatin-induced renal injury. Biochim. Biophys. Acta Mol. Basis Dis. 2019, 1865, 2504–2515. [Google Scholar] [CrossRef]
  51. Ozkok, A.; Edelstein, C.L. Pathophysiology of cisplatin-induced acute kidney injury. Biomed. Res. Int. 2014, 2014, 967826. [Google Scholar] [CrossRef] [PubMed]
  52. Zhang, G.; Ma, Y.; Wang, L.; Zhang, Y.; Zhou, J. Multispectroscopic studies on the interaction of maltol, a food additive, with bovine serum albumin. Food Chem. 2012, 133, 264–270. [Google Scholar] [CrossRef]
  53. Mi, X.J.; Hou, J.G.; Wang, Z.; Han, Y.; Ren, S.; Hu, J.N.; Chen, C.; Li, W. The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K/Akt and p53 signaling pathways. Sci. Rep. 2018, 8, 15922. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Ridzuan, N.R.A.; Rashid, N.A.; Othman, F.; Budin, S.B.; Hussan, F.; Teoh, S.L. Protective role of natural products in cisplatin-induced nephrotoxicity. Mini Rev. Med. Chem. 2019, 19, 1134–1143. [Google Scholar] [CrossRef] [PubMed]
Biomedicines 09 01283 g001 550
Figure 1. Chrysophanol alleviated H/R-induced cell viability. (A) Cell viability was determined using WST-1 assays for the indicated groups of cells. All data are presented as mean ± SD. n = 3. * p < 0.05. ** p < 0.01. (B) Changes in the expression of cleaved-caspase 3, Bax and Bcl-2. β-actin was used as an internal control. Cho: Chrysophanol. H/R: Hypoxia/reoxygenation. N: Normoxia.
Figure 1. Chrysophanol alleviated H/R-induced cell viability. (A) Cell viability was determined using WST-1 assays for the indicated groups of cells. All data are presented as mean ± SD. n = 3. * p < 0.05. ** p < 0.01. (B) Changes in the expression of cleaved-caspase 3, Bax and Bcl-2. β-actin was used as an internal control. Cho: Chrysophanol. H/R: Hypoxia/reoxygenation. N: Normoxia.
Biomedicines 09 01283 g001
Biomedicines 09 01283 g002 550
Figure 2. Chrysophanol alleviated H/R-induced ER stress and ferroptosis. (A) Changes in the expression of p-IRE1α. GAPDH was used as an internal control. (B) Changes in the expression of GPX4 and SLC7A11. β-actin was used as an internal control. Cho: Chrysophanol. H/R: Hypoxia/reoxigenation. N: Normoxia. n = 3.
Figure 2. Chrysophanol alleviated H/R-induced ER stress and ferroptosis. (A) Changes in the expression of p-IRE1α. GAPDH was used as an internal control. (B) Changes in the expression of GPX4 and SLC7A11. β-actin was used as an internal control. Cho: Chrysophanol. H/R: Hypoxia/reoxigenation. N: Normoxia. n = 3.
Biomedicines 09 01283 g002
Biomedicines 09 01283 g003 550
Figure 3. Chrysophanol reversed H/R-induced lipid ROS production. (A) Changes in cellular lipid ROS levels of control (without C11-BODIPY staining), N (cells grown in normal oxygen conditions without chrysophanol treatment), H/R (cells cultured in hypoxia/reoxygenation conditions, as described in Section 2), N + Cho (cells grown in normal oxygen conditions with 30 μM chrysophanol treatment), and H/R + Cho (cells cultured under hypoxia/reoxygenation conditions with 30 μM chrysophanol treatment) groups. (A) Cells were selected based on morphology. (B) ROS generation is expressed as mean fluorescence intensity. (C) Changes in cellular lipid ROS levels of control (without C11-BODIPY staining). H/R + DFO (cells cultured under hypoxia/reoxygenation conditions with 100 μM Desferal treatment for 1 h) groups (D) Lipid ROS generation is expressed as mean fluorescence intensity. (E) Cell viability was determined using WST-1 assays for the indicated groups of cells. Error bars represent the standard deviation from three independent replicates. n = 3. * p < 0.05.
Figure 3. Chrysophanol reversed H/R-induced lipid ROS production. (A) Changes in cellular lipid ROS levels of control (without C11-BODIPY staining), N (cells grown in normal oxygen conditions without chrysophanol treatment), H/R (cells cultured in hypoxia/reoxygenation conditions, as described in Section 2), N + Cho (cells grown in normal oxygen conditions with 30 μM chrysophanol treatment), and H/R + Cho (cells cultured under hypoxia/reoxygenation conditions with 30 μM chrysophanol treatment) groups. (A) Cells were selected based on morphology. (B) ROS generation is expressed as mean fluorescence intensity. (C) Changes in cellular lipid ROS levels of control (without C11-BODIPY staining). H/R + DFO (cells cultured under hypoxia/reoxygenation conditions with 100 μM Desferal treatment for 1 h) groups (D) Lipid ROS generation is expressed as mean fluorescence intensity. (E) Cell viability was determined using WST-1 assays for the indicated groups of cells. Error bars represent the standard deviation from three independent replicates. n = 3. * p < 0.05.
Biomedicines 09 01283 g003
Biomedicines 09 01283 g004 550
Figure 4. Chrysophanol reversed H/R-induced nuclear translocation of β-catenin and p65. (A) Cytosolic and nuclear fractions were isolated as described in “materials and methods”. Western blot analysis was performed to detect the subcellular localization of β-catenin and NF-κB using an antibody against the β-catenin and NF-κB subunit p65. β-actin was used as a cytosolic marker and fibrillarin as a nuclear marker. (B) The expression of β-catenin and nuclear p65 (nuclear p65) was quantified using ImageJ. All data are presented as the mean ± SD. ** p < 0.01. Immunofluorescence micrographs showed the distribution of β-catenin (C) and p65 (D). The β-catenin (C) and p65 (D) signal was intensely localized to the nucleus in HK-2 cells under H/R conditions (H/R) but was located in the cytoplasm under H/R conditions in the presence of 30 μM chrysophanol (H/R + Cho). The nuclei were counterstained with DAPI. Bar = 25 μm. (E) Chrysophanol alleviated the increasing in the IL-6 expression under H/R conditions. n = 3.
Figure 4. Chrysophanol reversed H/R-induced nuclear translocation of β-catenin and p65. (A) Cytosolic and nuclear fractions were isolated as described in “materials and methods”. Western blot analysis was performed to detect the subcellular localization of β-catenin and NF-κB using an antibody against the β-catenin and NF-κB subunit p65. β-actin was used as a cytosolic marker and fibrillarin as a nuclear marker. (B) The expression of β-catenin and nuclear p65 (nuclear p65) was quantified using ImageJ. All data are presented as the mean ± SD. ** p < 0.01. Immunofluorescence micrographs showed the distribution of β-catenin (C) and p65 (D). The β-catenin (C) and p65 (D) signal was intensely localized to the nucleus in HK-2 cells under H/R conditions (H/R) but was located in the cytoplasm under H/R conditions in the presence of 30 μM chrysophanol (H/R + Cho). The nuclei were counterstained with DAPI. Bar = 25 μm. (E) Chrysophanol alleviated the increasing in the IL-6 expression under H/R conditions. n = 3.
Biomedicines 09 01283 g004
Biomedicines 09 01283 g005 550
Figure 5. A summary diagram outlining the working mechanisms of chrysophanol in HK-2 cells under H/R conditions. (A) H/R increased apoptosis via upregulation of p-JNK, Bax, down-regulation of Bcl-2 and ER stress via upregulation of p-IRE1α/CHOP. Moreover, chrysophanol prevented apoptosis and ER stress by reversing the expression of indicated molecules. (B) H/R triggers ferroptosis via downregulation of GPX4 and SLC7A11, as well as lipid ROS overproduction. (B) Chrysophanol prevents H/R-induced ferroptosis via upregulation of GPX4 and SLC7A11, as well as decreasing lipid ROS accumulation.
Figure 5. A summary diagram outlining the working mechanisms of chrysophanol in HK-2 cells under H/R conditions. (A) H/R increased apoptosis via upregulation of p-JNK, Bax, down-regulation of Bcl-2 and ER stress via upregulation of p-IRE1α/CHOP. Moreover, chrysophanol prevented apoptosis and ER stress by reversing the expression of indicated molecules. (B) H/R triggers ferroptosis via downregulation of GPX4 and SLC7A11, as well as lipid ROS overproduction. (B) Chrysophanol prevents H/R-induced ferroptosis via upregulation of GPX4 and SLC7A11, as well as decreasing lipid ROS accumulation.
Biomedicines 09 01283 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lin, C.-H.; Tseng, H.-F.; Hsieh, P.-C.; Chiu, V.; Lin, T.-Y.; Lan, C.-C.; Tzeng, I.-S.; Chao, H.-N.; Hsu, C.-C.; Kuo, C.-Y. Nephroprotective Role of Chrysophanol in Hypoxia/Reoxygenation-Induced Renal Cell Damage via Apoptosis, ER Stress, and Ferroptosis. Biomedicines 2021, 9, 1283. https://doi.org/10.3390/biomedicines9091283

AMA Style

Lin C-H, Tseng H-F, Hsieh P-C, Chiu V, Lin T-Y, Lan C-C, Tzeng I-S, Chao H-N, Hsu C-C, Kuo C-Y. Nephroprotective Role of Chrysophanol in Hypoxia/Reoxygenation-Induced Renal Cell Damage via Apoptosis, ER Stress, and Ferroptosis. Biomedicines. 2021; 9(9):1283. https://doi.org/10.3390/biomedicines9091283

Chicago/Turabian Style

Lin, Chih-Hung, Han-Fang Tseng, Po-Chun Hsieh, Valeria Chiu, Ting-Yun Lin, Chou-Chin Lan, I-Shiang Tzeng, Huan-Nung Chao, Chia-Chen Hsu, and Chan-Yen Kuo. 2021. "Nephroprotective Role of Chrysophanol in Hypoxia/Reoxygenation-Induced Renal Cell Damage via Apoptosis, ER Stress, and Ferroptosis" Biomedicines 9, no. 9: 1283. https://doi.org/10.3390/biomedicines9091283

APA Style

Lin, C.-H., Tseng, H.-F., Hsieh, P.-C., Chiu, V., Lin, T.-Y., Lan, C.-C., Tzeng, I.-S., Chao, H.-N., Hsu, C.-C., & Kuo, C.-Y. (2021). Nephroprotective Role of Chrysophanol in Hypoxia/Reoxygenation-Induced Renal Cell Damage via Apoptosis, ER Stress, and Ferroptosis. Biomedicines, 9(9), 1283. https://doi.org/10.3390/biomedicines9091283

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop